Ticker
LEXXCompany Name
LEXARIA BIOSCIENCE CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -9.7M | -1574.8% | $ 615.92K |
3/31/2025 | $ -7.38M | -1403.57% | $ 525.92K |
12/31/2024 | $ -6.5M | -1308.73% | $ 496.92K |
9/30/2024 | $ -4.96M | -1068.11% | $ 464.28K |
6/30/2024 | $ -4.69M | -1244.28% | $ 376.85K |
3/31/2024 | $ -5.21M | -1349.48% | $ 386K |
12/31/2023 | $ -5.83M | -2111.8% | $ 276.01K |
9/30/2023 | $ -5.88M | -2599.92% | $ 226.21K |
6/30/2023 | $ -5.44M | -1595.16% | $ 340.79K |
3/31/2023 | $ -4.91M | -1413.34% | $ 347.36K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for LEXARIA BIOSCIENCE CORP is calculated as follows: CF - Operations [ $ -2.66M ] / Revenues [ $ 384.54K ]
(=) OCF % [ -692.58% ]
Minimum
Jun 30, 2022
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 78.12% |
average | 14.35% |
median | 12.67% |
std | 21.14% |